Helptext

Movies



Company Information

Company NameEurocine Vaccines AB
Company Idea

Eurocine Vaccines is a publicly listed, clinical-stage company developing nasal vaccines that meet important medical needs. The vaccines are developed up to proof of concept (clinical phase I/II) and licensed to partners for further development and commercialization. The company's proprietary vaccine adjuvant technologies, which are a key element of the nasal vaccines, are also offered to license partners for development in various indications.

Present focus is on partnering the nasal influenza vaccine program, Immunose™ FLU, which has shown proof of concept in a clinical study, and on preclinical development of a nasal vaccine against bacterial pneumonia.

Phone070-634 0171CEOHans Arwidsson
E-mailinfo(snabel-a)eurocine-vaccines(punkt)comChairm. of the BoardMichael Wolff Jensen
Homepagehttp://www.eurocine-vaccines.com 

Instrument Information

Full NameEurocine VaccinesShort NameEUCI
No of shares53,458,721Par Value0.11 SEK
TypeShareISIN codeSE0001839069

Price Information

+/-(0.09)
%-1.94
Latest4.54
High4.75
Low4.39
Volume43,943
Turnover (SEK)199,775
Market Cap (MSEK)243

Orders

VolumeBidAskVolume

Deals

TimeBuyerSellerPriceVolume
5:29 PMAVAMLI4.541,000
5:01 PMNONINT4.50165
4:54 PMNONAVA4.502,306
4:53 PMAVAAVA4.50460
4:52 PMNONAVA4.5090
4:52 PMAVAAVA4.511,555
4:52 PMNONAVA4.521,900
4:52 PMAVAAVA4.52500
4:52 PMAVAAVA4.531,000
4:52 PMAVAAVA4.55189

Scheduled Reports

DateReport
2017-05-18Delårsrapport tre




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se